Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: Homogenate binding and autoradiographic studies

Neurochemistry International

Volumn 30, Issue 3, 1997, Pages 277-290

  Huang, Ning ^a   Ase, Ariel R ^a   Hébert, Caroline ^a   Van Gelder, Nico M ^a,b   Reader, Tomas A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DENSITOMETRY; DOPAMINE BRAIN LEVEL; DRUG RECEPTOR BINDING; FOREBRAIN; GLOBUS PALLIDUS; HOMOGENATE; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; NEOSTRIATUM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SUBSTANTIA NIGRA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; HALOPERIDOL; MALE; NEOSTRIATUM; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SALICYLAMIDES;

ANIMALIA;

EID: 0031017866     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00093-9     Document Type: Article

References (64)

1. Allikmets, L. H., Žarkovsky, A. M. and Nurk, A. M. (1981) Changes in catalepsy and receptor sensitivity following chronic neuroleptic treatment. Eur. J. Pharm. 75, 145-147.
2. Andén, N. E. and Stock, G. (1973) Effects of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. J. Pharm. Pharmac. 25, 346-348.
3. Baldessarini, R. J. (1974) Tardive dyskineasis: an evaluation of the etiologic association with neuroleptic therapy. Can. Psychiat. Assoc. J. 19, 551-554.
4. Bannon, M. J. and Roth, R. H. (1983) Pharmacological of mesocortical dopamine neurons. Pharmac. Rev. 35, 53-68.
5. Barlow, R. B. (1983) Biodata Handling with Microcomputers. Elsevier Science Publishers, Amsterdam.
6. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6, 3177-3188.
7. Carlsson, A. and Lindqvist, M. (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmac. Toxic. 20, 140-144.
8. Chiodo, A. L. and Bunney, S. B. (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain neurons. J. Neurosci. 3, 1607-1619.
9. Chouinard, G., Vainer, J. L., Bélaner, M.-C., Turnier, L., Beaudry, P., Roy, J.-Y. and Milner, R. (1994) Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis. Progr. Neuro-Psychopharmac. Biol. Psychiat. 18, 1129-1141.
10. 1 receptor antagonist. Abstracts 30th Annual meeting ACNP, Puerto Rico, 9-13 December..
11. Coward, D. M., Imperato, A., Urwyler, S. and White, T. G. (1989) Biochemical and behavioral properties of clozapine. Psychopharmacology Suppl. 99, 6-S12.
12. Creese, I., Burt, D. R. and Snyder, S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481-483.
13. 1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J. Neurosci. 9, 125-133.
14. 3H]SCH23390. Eur. J. Pharmac. 108, 323-325.
15. 2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents. Synapse 4, 378-386.
16. 3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. J. Pharmac. exp. Ther. 250, 696-706.
17. 1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536, 287-296.
18. 1 receptors drugs that attenuate both positive and negative symptons of schizophrenia? A pilot study in Java monkeys. Neuropsychopharmacology 2, 191-199.
19. Farde, L. and Nordström, A.-L. (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br. J. Psychiatr. 160(Suppl. 17), 30-33.
20. 2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology Suppl. 99, 28-S31.
21. Frank, H. and Althoen, S. C. (1994) Statistics: Concepts and Applications. Cambridge University Press, New York.
22. 32 antagonism in extrapyramidal functions. Br. J. Psychiatr. 160(Suppl. 17), 34-37.
23. Giardino, L., Calza, L., Piazza, P. V. and Amato, G. (1991) Multiple neurochemical action of clozapine: a quantitative autoradiographic study of DA2, opiate and benzodiazepine receptors in the rat brain after long-term treatment. J. Neural Transm. 83, 189-203.
24. Gupta, S. K. and Mishra, R. K. (1992) Effects of chronic treatment of haloperidol and clozapine on levels of G-protein subunits in rat striatum. J. molec. Neurosci. 3, 197-201.
25. 3H-raclopride. J. Neural Transm. 73, 7-21.
26. Hallman, H. and Jonsson, G. (1984) Neurochemical studies on central dopamine neurons-regional characterization of dopamine turnover. Med. Bio. 62, 198-209.
27. Hansen, L. and Gerlach, J. (1991) Dopamine 1 and 2 receptor interaction in the development of dystonia and hypersensibility in cebus monkeys. Biol. Psychiat. 29, 275S.
28. Jenner, P. and Marsden, C. D. (1985) Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology 26, 931-940.
29. 2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopamine innervation. Brain Res. 338, 209-218.
30. Klawans, H. L. Jr (1973) The pharmacology of tardive dyskinesias. Am. J. Psychiat. 130, 82-86.
31. 3H]raclopride. Neurosci. Lett. 66, 85-90.
32. Leatherbarrow, R. J. (1987) ENZFITTER. A Non-Linear Regression Data Analysis Program for the IBM PC (and) True Compatibles, pp. 1-91. Elsevier Science Publishers, Amsterdam.
33. 18FESP. In: New Generation of Antipsychotic Drugs: Novel Mechanisms of Action (Brunello, N., Mendlewicz, J. and Racagni G., Eds). Int Acad. Biomed. Drug Res. 4, 130-135.
34. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265-275.
35. Marsden, C. D. (1975) The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias). Modern Trends Neurol. 6, 141-166.
36. Marsden, C. D. and Jenner, P. (1990) The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychol. Med. 10, 55-72.
37. Meltzer, H. Y. (1994) An overview of the mechanism of action of clozapine. J. clin. Psychiatr. Suppl. B55, 47-52.
38. 2 pKi values. J. Pharmac. exp. Ther. 251, 238-246.
39. 2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmac. Bull. 25, 390-392.
40. Meltzer, H. Y., Zhang, Y. and Stockmeier, C. (1990) Effects of typical and atypical antipsychotic drugs (APD) on frontal cortical (FC) serotonin2 (5-HT2) and striatal (STR) dopamine2 (DA2) binding in vivo. Soc. Neurosci. Abstr. 16, 586.
41. 2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. Neuropharmacoloygy 26, 477-480.
42. Molina-Holgado, E., Dewar, K. M., Grondin, L., van Gelder, N. M. and Reader, T. A. (1993) Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei. J. Neurosci. Res. 35, 409-418.
43. Molina-Holgado, E., van Gelder, N. M., Dewar, K. M. and Reader, T. A. (1995) Dopamine receptor alterations correlate with increased GABA levels in adult rat neostriatum: effects of a neonatal 6-hydroxydopamine denervation. Neurochem. Int. 27, 443-451.
44. O'Dell, S. J., La Hoste, G. J., Widmark, C. B., Shapiro, R. M., Potkin, S. G. and Marshall, J. F. (1990) Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse 6, 146-153.
45. 2 receptors in adult rat neostriatum after neonatal dopamine denervation. Correlation of quantitative data from ligand binding auto radiography, in situ hybridization and iontophoresis. Neuroscience 57, 635-648.
46. 1 receptors in cerebral cortex and neostriatum: evidence for heterogeneity in affinity states and cortical distribution. J. Neurochem. 50, 451-463.
47. 2 receptors. Molec. Neurobiol. 6, 425-450.
48. Reader, T. A., Radja, F., Dewar, K. M. and Descarries, L. (1995) Denervation, hyperinnervation and interactive regulation of dopamine and serotonin receptors. Ann. N. Y. Acad. Sci. 757, 293-310.
49. 2-receptors in the striatum of the rat. Neurochem. Res. 17, 387-395.
50. Sauvé, Y. and Reader, T. A. (1988) Effects of α-methyl-p-tyrosine on monoamines and catecholamine receptors in rat cerebral cortex and neostriatum. Neurochem. Res. 13, 807-815.
51. Scatchard, G. (1949) The attraction of protein for small molecules and ions. Ann. N.Y. Acad. Sci. 51, 660-672.
52. Scatton, B. (1977) Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur. J. Pharmac. 46, 363-369.
53. Scatton, B., Glowinski, J. and Julou, L. (1976) Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics. Brain Res. 109, 184-189.
54. See, R. E. and Chapman, M. A. (1994) The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals. Crit. Rev. Neurobiol. 8, 85-124.
55. See, R. E., Toga, A. W. and Ellison, G. (1990) Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical; neuroleptic in rats. J. Neural Transm. 82, 93-109.
56. Seeman, P. (1980) Brain dopamine receptors. Pharmac. Rev. 32, 229-313.
57. Seeman, P. (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1, 133-152.
58. Seeman, P., Lee, T., Chau-Wong, M. and Wong, K. (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261, 717-721.
59. 4 receptors elevated in schizophrenia. Nature 365, 441-445.
60. Snyder, S. H., Greenberg, D. and Yamamura, H. I. (1974) Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects. J. Psychiat. Res. 11, 91-95.
61. Van Rossum, J. M. (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch. Int. Pharmacodyn. Ther. 160, 492-494.
62. Waldmeir, P. C. and Maître, L. (1976) Clozapine: reduction of the initial dopamine turnover increase by repeated treatment. Eur. J. Pharmac. 38, 197-202.
63. 2-receptor occupancy during antipsychotic drug treatment. Progr. Neuro-Psychopharmac. Biol. Psychiatr. 14, 759-767.
64. Wilk, S., Watson, E. and Stanley, M. (1975) Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine. J. Pharmac. exp. Ther. 195, 265-270.